Your session is about to expire
Arthrotec vs Vimovo
Introduction
For patients with osteoarthritis or rheumatoid arthritis, certain drugs that decrease the levels of chemicals in the body causing pain and inflammation can help manage symptoms. Arthrotec and Vimovo are two such drugs commonly prescribed to treat these conditions. Both medications combine a non-steroidal anti-inflammatory drug (NSAID) with another substance to help protect against stomach ulcers, which can be a common side effect of NSAIDs. Arthrotec comprises diclofenac, an NSAID that works by reducing substances in the body that cause pain and inflammation, combined with misoprostol which helps reduce stomach acid and protect the stomach lining. On the other hand, Vimovo combines naproxen - another NSAID working similarly to diclofenac - with esomeprazole, a proton pump inhibitor used for reducing production of acid in the stomach.
Arthrotec vs Vimovo Side By Side
| Attribute | Arthrotec | Vimovo |
|---|---|---|
| Brand Name | Arthrotec | Vimovo |
| Contraindications | Should not be taken with anticoagulants like warfarin, in late pregnancy, or by those with a history of stomach ulcers or gastrointestinal bleeding. | Should not be taken with anticoagulants like warfarin, in late pregnancy, or by those with a history of stomach ulcers or gastrointestinal bleeding. |
| Cost | Around $320 for 60 tablets (50 mg/200 mcg) | Around $2,800 for 30 tablets (500 mg/20 mg) |
| Generic Name | Diclofenac/Misoprostol | Naproxen/Esomeprazole |
| Most Serious Side Effect | Severe allergic reactions, bleeding, liver problems, kidney problems, high blood pressure, heart attack symptoms. | Allergic reactions, heart disease symptoms, liver problems, kidney issues, blood disorders, severe skin reactions. |
| Severe Drug Interactions | Anticoagulants (blood thinners) like warfarin. | Anticoagulants (blood thinners) like warfarin. |
| Typical Dose | 50-200 mg twice daily, often starting at 50 mg twice a day. | 375-500 mg twice daily, not exceeding 1500 mg/day. |
What is Arthrotec?
Arthrotec (a combination of diclofenac and misoprostol) was a significant advancement in the NSAID class of drugs, which marked an important stride over traditional non-steroidal anti-inflammatory drugs. Arthrotec first received FDA approval in 1997. It works by reducing substances that cause pain and inflammation while also protecting the stomach from ulcers, effectively maintaining balance between treatment and prevention. Arthrotec is prescribed for the treatment of various forms of arthritis. The drug has a direct influence on prostaglandins with only minor interference on other inflammatory mediators, resulting in it having fewer side effects than other NSAIDs that have stronger impacts on these other components.
On the other hand, Vimovo (a combination of naproxen and esomeprazole) is another medication used to relieve symptoms such as stiffness, swelling, inflammation caused by conditions like osteoarthritis and rheumatoid arthritis while simultaneously lowering risk of developing gastric ulcers. Even though both serve similar purposes, they have different active ingredients implying distinct mechanisms; thus differences may be observed in their effectiveness or potential side effects.
What conditions is Arthrotec approved to treat?
Arthrotec is approved for the treatment of various conditions, including:
- Osteoarthritis and rheumatoid arthritis in patients at high risk of developing NSAID-induced stomach and intestinal ulcers
- As an analgesic for the management of acute pain
Vimovo, on the other hand, is used to treat certain conditions such as:
- Rheumatoid arthritis
- Osteoarthritis
- Ankylosing spondylitis (a type of joint disease that affects your spine)
Both drugs are designed to decrease pain/inflammation from arthritis while minimizing gastrointestinal side effects.
How does Arthrotec help with these illnesses?
Arthrotec works to manage arthritis symptoms by reducing the amount of prostaglandins, chemicals involved in inflammation and pain signals, available in the body. It does this by inhibiting cyclooxygenase (COX), an enzyme that promotes their production. Prostaglandins play a crucial role in processes like inflammation, blood flow, and the formation of blood clots. In people with conditions like osteoarthritis or rheumatoid arthritis, overproduction of these compounds can lead to painful joint inflammation and damage. By reducing prostaglandin levels through COX inhibition, Arthrotec can alleviate these inflammatory effects and help patients manage their condition more comfortably.
What is Vimovo?
Vimovo is a combination drug that contains naproxen, an NSAID (nonsteroidal anti-inflammatory drug), and esomeprazole magnesium, a proton pump inhibitor. It works by reducing substances in the body that cause inflammation and pain while simultaneously decreasing the amount of acid produced in the stomach. Vimovo was first approved by the FDA in 2010.
As Vimovo is not just an NSAID like Arthrotec (which combines diclofenac with misoprostol), it does more than just reduce inflammation and relieve pain. Its action on stomach acid means it can also help prevent ulcers, which are a common side effect of long-term NSAID use. This makes its side-effect profile different to that of typical NSAIDs such as Arthrotec - particularly because it's less likely to cause gastrointestinal issues like stomach bleeding or ulceration. The effects of Vimovo can be beneficial for managing conditions such as osteoarthritis or rheumatoid arthritis, especially in patients who have had or are at risk for stomach ulcers.
What conditions is Vimovo approved to treat?
Vimovo, a combination of naproxen and esomeprazole, is typically prescribed for the following conditions:
- Osteoarthritis
- Rheumatoid arthritis
- Ankylosing spondylitis
Especially useful in cases where there's an increased risk of gastric ulcers due to naproxen use, Vimovo provides a protective effect against this potential side effect.
How does Vimovo help with these illnesses?
Vimovo, like Arthrotec, is a combination medication that pairs an anti-inflammatory drug (naproxen) with a proton pump inhibitor (esomeprazole). Naproxen works by blocking the production of prostaglandins, substances in the body that cause inflammation. This reduces inflammation and pain in conditions such as arthritis. Esomeprazole is included to decrease the risk of gastrointestinal ulcers associated with naproxen use. It achieves this by reducing the amount of acid produced in your stomach. Vimovo's dual action can be particularly useful for patients who require long-term treatment and are at high risk for developing gastric ulcers or have had them before. While both drugs serve similar functions, Vimovo has been found to provide more consistent day-to-day symptom control than Arthrotec.
How effective are both Arthrotec and Vimovo?
Both Arthrotec and Vimovo are drugs used to treat arthritis symptoms while also providing gastrointestinal protection. They were approved by the FDA within a few years of each other, with Arthrotec being first in 1997, followed by Vimovo in 2010. Since they act on different bodily systems, they may be prescribed under different circumstances.
The effectiveness of both drugs was directly studied in multiple clinical trials; these studies showed comparable efficacy in managing arthritis symptoms like joint pain and swelling as well as similar safety profiles due to their gut-protecting components (misoprostol for Arthrotec and esomeprazole for Vimovo). In most cases, no significant differences were found between patients receiving either drug when considering metrics such as overall pain relief or reduction in inflammation.
A review published in 2004 indicated that Arthrotec is effective at reducing arthritis-related pain starting from the first week of treatment. Its side effect profile is generally favorable over many other nonsteroidal anti-inflammatory drugs (NSAIDs), particularly because it includes misoprostol to prevent NSAID-induced stomach ulcers. This makes it a popular choice among rheumatologists globally.
On the other hand, evidence suggests that Vimovo seems not only effective at relieving arthritis symptoms but also efficient at preventing gastric ulcer formation thanks to its combination with esomeprazole - a proton pump inhibitor known for its high efficacy against acid disorders. Nonetheless, except for specific cases where ulcer prevention is paramount or previous history of NSAID intolerance exists, traditional NSAIDs are often considered before resorting to these combo-drugs due to cost considerations. Further research comparing standalone use versus co-prescribed usage alongside traditional NSAIDs will continue informing best practices regarding their prescription.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Arthrotec typically prescribed?
Oral dosages of Arthrotec range from 50-200 mg twice daily, but research has shown that 50 mg twice a day is often adequate for managing symptoms of osteoarthritis and rheumatoid arthritis. The dosage can be increased after a few weeks if there is no response or if the patient's condition worsens. Meanwhile, Vimovo typically starts at 375-500 mg twice daily which may also be adjusted based on individual response and tolerance to treatment. In either case, it's crucial not to exceed the maximum prescribed dose in order to avoid potential side effects.
At what dose is Vimovo typically prescribed?
Vimovo treatment typically begins with a dosage of 375-500 mg twice daily. Dose can then be adjusted based on the severity and response to the treatment, not exceeding 1500 mg/day divided into two doses, spaced approximately 12 hours apart. If there is no response or insufficient relief from symptoms at this dose after several weeks, your doctor may consider an alternative treatment option. It's important to remember that Vimovo should be taken at least 30 minutes before meals for optimal absorption and maximum effectiveness.
What are the most common side effects for Arthrotec?
Common side effects of Arthrotec may include:
- Abdominal pain
- Indigestion, dyspepsia (burning, discomfort or pain in the digestive tract)
- Diarrhea
- Nausea
- Gas, bloating
- Vomiting
- Constipation
- Headache
- Dizziness
In contrast, Vimovo can cause similar side effects such as:
- Nausea and vomiting
- Diarrhea or constipation
- Gas and heartburn
- Dizziness
- Sweating
- Swelling hands/ankles/feet (edema)
Note that both drugs can potentially lead to more serious complications. It is crucial to consult your healthcare provider for advice tailored to you before starting any new medication regimen.
Are there any potential serious side effects for Arthrotec?
While rare, Arthrotec can cause potentially serious side effects. These include:
- Signs of severe allergic reaction: hives; difficulty breathing or swallowing; swelling in your face, lips, tongue or throat
- Bleeding that doesn't stop including bloody or tarry stools and coughing up blood or vomit that looks like coffee grounds
- Severe liver problems: nausea, upper stomach pain, itching, tired feeling, flu-like symptoms with loss of appetite and jaundice (yellowing of the skin or eyes)
- Kidney problems: little to no urination; painful/difficult urination; swelling in feet/ankles
- High blood pressure symptoms: severe headache/blurred vision/pounding in neck/chest
- Heart attack symptoms: chest/jaw/left arm pain/shortness of breath
On the other hand Vimovo also has potential adverse effects such as:
- Allergic reactions similar to Arthrotec's described above.
- Serious bleeding from stomach/intestine.
- Liver problems similar to those caused by Arthrotec.
- Kidney issues identical to those linked with Arthrotec use.
- New/worsening heart failure.
If you experience any concerning side effects from either medication immediately seek medical attention.
What are the most common side effects for Vimovo?
When it comes to Vimovo, potential side effects can include:
- Headache or dizziness
- Nausea, vomiting, stomach pain, indigestion
- Ulcers or bleeding in the stomach or intestines
- Rash or itching
- Fast heartbeat
- Sleep problems (insomnia)
- Swelling of legs and arms due to fluid retention
- Constipation or diarrhea
- Changes in liver function tests
It's important to note that these are potential side effects and not everyone will necessarily experience them. Always consult with your healthcare provider for personalized advice.
Are there any potential serious side effects for Vimovo?
While Vimovo is generally considered safe, it can sometimes lead to serious side effects. These may include:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling in your face, lips, tongue, or throat
- Symptoms related to heart disease like chest pain spreading to the jaw or shoulder, sudden numbness or weakness on one side of the body, slurred speech
- Liver problems which may involve nausea, upper stomach pain and itching
- Kidney issues characterized by little or no urination
- Blood disorders leading to easy bruising or bleeding and unusual tiredness
- Severe skin reactions that involve fever, sore throat and burning eyes
If you experience any of these symptoms while taking Vimovo stop using the drug immediately and consult with your healthcare provider.
Contraindications for Arthrotec and Vimovo?
Both Arthrotec and Vimovo, as with most other non-steroidal anti-inflammatory drugs (NSAIDs), may increase the risk of serious cardiovascular events such as heart attacks or strokes. If you experience chest pain, shortness of breath, weakness on one side of your body, or slurred speech while taking these medications, please seek immediate medical attention.
Neither Arthrotec nor Vimovo should be taken if you are currently using anticoagulants (blood thinners) like warfarin. Always inform your physician about all the medications you are taking; major interactions can occur between NSAIDs and blood thinners which could lead to increased bleeding risks.
Furthermore, both Arthrotec and Vimovo require special consideration for those with a history of stomach ulcers or gastrointestinal bleeding. These conditions may become exacerbated by the use of NSAIDs.
Additionally, it is important to note that neither medication should be used in late pregnancy due to potential harm to the baby. Always consult your doctor before starting any new medication regimen.
How much do Arthrotec and Vimovo cost?
For the brand name versions of these drugs:
- The price of 60 tablets of Arthrotec (50 mg/200 mcg) averages around $320, which works out to about $5.33/day if taken as directed.
- The price of 30 tablets of Vimovo (500 mg/20 mg) is around $2,800 or approximately a staggering $93/day with regular dosage.
Thus, if you are on daily medication for arthritis pain and inflammation, then brand-name Arthrotec is considerably less expensive on a per-day treatment basis compared to Vimovo. However, it's crucially important that cost not be the primary consideration in determining which drug suits your needs best - each has unique benefits and side effects that should be discussed with your doctor.
As far as generic equivalents go:
-
Generic diclofenac/misoprostol (the active ingredients in Arthrotec), costs significantly less than its brand-name counterpart. A pack size of 60 capsules can range from about $45-$120 depending on pharmacy pricing – resulting in an approximate daily cost between $0.75–$2.
-
There currently isn't a generic equivalent available for Vimovo at this time; hence its higher cost persists across all platforms.
Remember prices may vary greatly based upon location and insurance coverage among other factors.
Popularity of Arthrotec and Vimovo
Arthrotec and Vimovo are both combination medications that are commonly prescribed for the management of arthritis-related pain, with an added component to help protect against stomach ulcers which can be a common side effect of nonsteroidal anti-inflammatory drugs (NSAIDs).
In 2020, Arthrotec, a combined formulation of diclofenac and misoprostol, was estimated to have been prescribed to about 1.3 million people in the U.S., accounting for just over 2% of NSAID prescriptions. This medication has seen relatively stable usage rates over the past decade.
Vimovo, on the other hand combines naproxen with esomeprazole. It was prescribed to approximately 300 thousand people in the US in 2020. Despite representing less than half a percent of NSAID prescriptions overall, Vimovo's usage has been increasing modestly since its introduction into market due mainly to aggressive marketing efforts by its manufacturer.
Conclusion
Both Arthrotec and Vimovo have been widely used to manage pain in patients with conditions like arthritis. They're supported by numerous clinical studies showing that they are more effective than placebo treatments. These drugs combine a nonsteroidal anti-inflammatory drug (NSAID) with a stomach-protective agent, which helps to reduce the risk of gastrointestinal side effects common with NSAIDs. Arthrotec combines diclofenac, an NSAID, with misoprostol while Vimovo merges naproxen, another type of NSAID, together with esomeprazole.
Arthrotec may be chosen as the first-line treatment due to its efficient relief from symptoms and limited gastrointestinal side-effects compared to other standalone NSAIDs. Vimovo can be considered for patients who do not respond well initially or are sensitive to diclofenac or misoprostol found in Arthrotec but still require an NSAID for their condition.
Both medications come in generic form offering significant cost savings especially for those paying out-of-pocket expenses. It's important for users of both Arthrotec and Vimovo know that it might take some time before they notice any improvements in their symptoms.
The adverse effect profiles are similar between these two drugs; however, certain individuals might find one product better tolerated over the other depending on personal sensitivity levels towards individual components within each formulation. Any unusual changes should immediately prompt consultation with your healthcare provider.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Choi, Y., Han, H., Shin, D., Lim, K. S., & Yu, K.-S. (2015, July). Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers. Drug Design, Development and Therapy. Informa UK Limited.http://doi.org/10.2147/dddt.s86725